Biomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients

被引：8

作者：

Laza-Briviesca, R. ^{[1
]}

Cruz-Bermudez, A. ^{[1
]}

Casarrubios, M. ^{[1
]}

Nadal, E. ^{[2
]}

Insa, A. ^{[3
]}

Garcia Campelo, R. ^{[4
]}

De Dios Alvarez, N. ^{[5
]}

Domine, M. ^{[6
]}

Majem, M. ^{[7
]}

Rodriguez-Abreu, D. ^{[8
]}

Calvo De Juan, V. ^{[1
]}

Martinez-Marti, A. ^{[9
,10
]}

De Castro Carpeno, J. ^{[11
]}

Cobo, M. ^{[12
]}

Lopez-Vivanco, G. ^{[13
]}

Del Barco, E. ^{[14
]}

Bernabe, R. ^{[15
]}

Vinolas, N. ^{[16
]}

Barneto, I. ^{[17
]}

Viteri, S. ^{[18
]}

Massuti, B. ^{[19
]}

Provencio, M. ^{[1
]}

机构：

[1] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain

[2] Inst Catala Oncol, Med Oncol, Barcelona, Spain

[3] Hosp Clin Univ, Clin Fdn Incliva, Valencia, Spain

[4] Hosp Univ A Coruna, La Coruna, Spain

[5] Hosp Univ Vigo, Pontevedra, Spain

[6] Hosp Fdn Jimenez Iis Fjd, Madrid, Spain

[7] Hosp La Santa Creu & St Pau, Barcelona, Spain

[8] Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain

[9] Vall Dhebron Univ Hosp, Barcelona, Spain

[10] Inst Oncol Vhio, Barcelona, Spain

[11] Hosp Univ La Paz, Madrid, Spain

[12] Univ Hosp Reg Malaga, Malaga, Spain

[13] Hosp Univ Cruces, Baracaldo, Spain

[14] Hosp Univ Salamanca, Salamanca, Spain

[15] Hosp Univ Virgen Del Rocio, Seville, Spain

[16] Clin Hosp, Oncol, Barcelona, Spain

[17] Hosp Univ Reina Sofia, Cordoba, Spain

[18] Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosell, Grp Quironsalud, Barcelona, Spain

[19] Hosp Gen Alicante, Alicante, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

stage IIIA NSCLC; biomarkers; neo-adjuvant chemo-immunotherapy;

D O I：

10.1016/j.jtho.2019.08.1515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.04-10

引用

页码：S711 / S711

页数：1